A high-content screening platform for antiviral drug discovery using a recombinant African swine fever virus
Challika Kaewborisuth , Artit Khonsanit , Donnaya Thanakitpipattana , Nathiphat Tanwattana , Benjamas Liwnaree , Jennifer Luangsa-ard , Nopporn Chutiwitoonchai
Animal Diseases ›› 2026, Vol. 6 ›› Issue (1) : 3
A high-content screening platform for antiviral drug discovery using a recombinant African swine fever virus
African swine fever (ASF), caused by African swine fever virus (ASFV), is a devastating disease of domestic pigs with mortality rates approaching 100%, leading to severe global economic losses. No effective vaccines or antivirals are available, highlighting the urgent need for novel therapeutic strategies and efficient screening tools. We developed a recombinant ASFV-expressing dual reporter (mCherry and NanoLuc), rASFV_mChNluc, and established a high-content screening (HCS) platform optimized for cost-effective, low-labor analysis via the mCherry reporter. The assay demonstrated excellent robustness (Z′-factor = 0.669±0.064) and successfully verified the activity of the known ASFV inhibitor AraC, confirming inhibition at the postinfection stage. Screening of an in-house fungal extract library (493 extracts) identified 25 hits (5.07%) that reduced viral infectivity to < 5%. Extracts from the insect fungi Beauveria neobassiana and Samsoniella aurantia showed potent activity, with an SI > 62.81 (EC₅₀ = 1.99±0.71 µg/mL) and an SI > 42.92 (EC₅₀ = 11.65±2.99 µg/mL), respectively. Time-of-addition assays indicated that B. neobassiana acts at multiple replication stages, whereas S. aurantia targets the postinfection stage. This study establishes a robust ASFV HCS platform for efficient high-throughput antiviral discovery and highlights fungi as a promising source of novel ASFV inhibitors.
African swine fever virus / Antiviral discovery / High-content screening / Fungal extract
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
Kuephadungphan, W., S. E. Helaly, C. Daengrot, S. Phongpaichit, J. J. Luangsa-Ard, V. Rukachaisirikul, and M. Stadler. 2017. Akanthopyrones A-D, alpha-Pyrones Bearing a 4-O-Methyl-beta-d-glucopyranose Moiety from the Spider-Associated Ascomycete Akanthomyces novoguineensis. Molecules 22 (7). https://doi.org/10.3390/molecules22071202. |
| [10] |
Kwon, H. I., D. T. Do, H. Van Vo, S. C. Lee, M. H. Kim, D. T. T. Nguyen, T. M. Tran, Q. T. V. Le, T. T. N. Ngo, N. M. Nguyen, J. Y. Lee, and T. T. Nguyen. 2022. Development of optimized protocol for culturing African swine fever virus field isolates in MA104 cells. Canadian Journal of Veterinary Research 86 (4): 261–268. https://doi.org/10.21203/rs.3.rs-754616/v1. |
| [11] |
|
| [12] |
|
| [13] |
Li, Z., W. Chen, Z. Qiu, Y. Li, J. Fan, K. Wu, X. Li, M. Zhao, H. Ding, S. Fan, and J. Chen. 2022. African Swine Fever Virus: A Review. Life (Basel) 12 (8). https://doi.org/10.3390/life12081255. |
| [14] |
|
| [15] |
|
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
Ramirez-Medina, E., E. Vuono, V. O'Donnell, L. G. Holinka, E. Silva, A. Rai, S. Pruitt, C. Carrillo, D. P. Gladue, and M. V. Borca. 2019. Differential Effect of the Deletion of African Swine Fever Virus Virulence-Associated Genes in the Induction of Attenuation of the Highly Virulent Georgia Strain. Viruses 11 (7). https://doi.org/10.3390/v11070599. |
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
Sum, W. C., N. Mitschke, H. Schrey, K. Wittstein, H. Kellner, M. Stadler, and J. C. Matasyoh. 2022. Antimicrobial and cytotoxic cyathane-xylosides from cultures of the Basidiomycete dentipellis fragilis. Antibiotics (Basel) 11 (8). https://doi.org/10.3390/antibiotics11081072. |
| [26] |
|
| [27] |
Thaweerattanasinp, T., C. Kaewborisuth, R. Viriyakitkosol, J. Saenboonrueng, A. Wanitchang, N. Tanwattana, C. Sonthirod, D. Sangsrakru, W. Pootakham, S. Tangphatsornruang, et al. 2024. Adaptation of African swine fever virus to MA-104 cells: Implications of unique genetic variations. Veterinary Microbiology 291:110016. https://doi.org/10.1016/j.vetmic.2024.110016. |
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
The Author(s)
/
| 〈 |
|
〉 |